Login / Signup

Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study.

Rajshekhar ChakrabortyDivaya BhutaniMarkus MaparaRan ReshefMathew S MaurerJai RadhakrishnanSuzanne Lentzsch
Published in: American journal of hematology (2023)
Keyphrases
  • multiple myeloma
  • cardiovascular events
  • risk factors
  • type diabetes
  • stem cells
  • replacement therapy